Evidence map›Paper›PMID 21626440›Full record

ArticleImmunogenetics2011

Chinese origin rhesus macaque major histocompatibility complex class I molecules promiscuously present epitopes from SIV associated with molecules of Indian origin; implications for immunodominance and viral escape.

Nicholas James Maness, Andrew D Walsh, Richard A Rudersdorf, Priscilla A Erickson, Shari M Piaskowski, Nancy A Wilson, David I Watkins

Abstract read
In one paragraph

Article in Immunogenetics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Nicholas James ManessDepartment of Pathology and Laboratory Medicine, University of Wisconsin-Madison, WI 53711, USA. njmaness@wisc.edu
Andrew D Walsh
Richard A Rudersdorf
Priscilla A Erickson
Shari M Piaskowski
Nancy A Wilson
David I Watkins
University of Wisconsin–Madison · US

Funding

ZOLEDRONATE PREVENTS BONE LOSS IN OVARIECTOMIZED RHESUS MONKEYSP51RR000167 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI WATKINS, DAVID I · 1985 to 2011
$106.7M
MHC-bound, SIV-derived, CTL &HTL EpitopesR24RR015371 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI WATKINS, DAVID I · 2000 to 2011
$8.1M
The Functional Significance of CTL EscapeR37AI052056 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI WATKINS, DAVID I · 2008 to 2017
$7.1M
MHC TYPING OF MACAQUES USED IN AIDS RESEARCHR24RR016038 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI WATKINS, DAVID I · 2001 to 2011
$6.3M
EXTRAMURAL RES FACIL CONST: REPRODUCTIVE, GROWTH &DVMT, MENOPAUSEC06RR020141 · NCRR · UNIVERSITY OF WISCONSIN MADISON · PI CADWALLADER, MARTIN · 2004 to 2004
$3.6M
Minigene Vaccination with Early Presented Viral ProteinsR01AI076114 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI RAKASZ, EVA GIZELLA · 2007 to 2011
$3.3M
EXTRAMURAL REGIONAL FACILITIES CONSTRUCTIONC06RR015459 · NCRR · UNIVERSITY OF WISCONSIN MADISON · PI CADWALLADER, MARTIN · 2000 to 2000
$1.9M
MHC Typing of Macaques Used in AIDS ResearchR24OD011161 · OD · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI WATKINS, DAVID I · 2012 to 2013
$1.3M
Cryptic ORFs as a vaccine for HIVR21AI081590 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI WATKINS, DAVID I · 2009 to 2010
$386k
NCRR NIH HHS C06 RR015459NCRR NIH HHS C06 RR020141NCRR NIH HHS P51 RR000167NCRR NIH HHS R24 RR015371NCRR NIH HHS R24 RR016038NCRR NIH HHS RR020141-01NCRR NIH HHS RR15459-01NIAID NIH HHS R01 AI076114NIAID NIH HHS R21 AI081590NIAID NIH HHS R37 AI052056NIAID NIH HHS R37AI052056NIH HHS R24 OD011161PHS HHS R01 A1049120
6 · The paper itself

Abstract

The presentation of identical peptides by different major histocompatibility complex class I (MHC-I) molecules, termed promiscuity, is a controversial feature of T cell-mediated immunity to pathogens. The astounding diversity of MHC-I molecules in human populations, presumably to enable binding of equally diverse peptides, implies promiscuity would be a rare phenomenon. However, if it occurs, it would have important implications for immunity. We screened 77 animals for responses to peptides known to bind MHC-I molecules that were not expressed by these animals. Some cases of supposed promiscuity were determined to be the result of either non-identical optimal peptides or were simply not mapped to the correct MHC-I molecule in previous studies. Cases of promiscuity, however, were associated with alterations of immunodominance hierarchies, either in terms of the repertoire of peptides presented by the different MHC-I molecules or in the magnitude of the responses directed against the epitopes themselves. Specifically, we found that the Mamu-B*017:01-restricted peptides Vif HW8 and cRW9 were also presented by Mamu-A2*05:26 and targeted by an animal expressing that allele. We also found that the normally subdominant Mamu-A1*001:01 presented peptide Gag QI9 was also presented by Mamu-B*056:01. Both A2*05:26 and B*056:01 are molecules typically or exclusively expressed by animals of Chinese origin. These data clearly demonstrate that MHC-I epitope promiscuity, though rare, might have important implications for immunodominance and for the transmission of escape mutations, depending on the relative frequencies of the given alleles in a population.

Indexed as

AllelesAmino Acid SequenceAnimalsBase SequenceChinaGenes, MHC Class IHistocompatibility Antigens Class IImmunodominant EpitopesIndiaMacaca mulattaMolecular Sequence DataSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusHistocompatibility Antigens Class IImmunodominant Epitopes

Identifiers

PMID21626440
PMCPMC3156284
OpenAlexW2057910066

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.